Preventing suicide: A critical next step

Doctors may in the future be able to take a blood test to determine if a patient is suicidal, hopefully decreasing the number of people taking their own lives.

In Australia, suicide is the number one cause of death for people between the ages of 15 and 44 (Australian Bureau of Statistics).

Research published in Neuropsychopharmacology has found that a chemical in the brain called quinolinic acid is linked to suicidal behaviour. Quinolinic acid is produced as a by-product of inflammation.

The research shows that people who are suicidal have twice as much quinolinic acid in their bodies as healthy individuals. Those who have the strongest desire to kill themselves have the highest levels of the acid.

The increased acid indicates greater signalling of the between . The acid acts like a chemical switch to make the glutamate send more signals to . Until now the focus for depression has remained on another neurotransmitter, serotonin.

The researchers took the samples of the quinolinic acid from the spinal fluid of 100 patients in Sweden. Two-thirds of the participants had been admitted to hospital after a and the rest were healthy.

UNSW researchers, who are world-leaders in research on quinolinic acid, were brought in to analyse the samples.

"We have previously demonstrated that the neurotoxin quinolinic acid is involved in the neuroinflammatory response in several including Alzheimer's disease, autism and schizophrenia," says Conjoint Associate Professor Gilles Guillemin from UNSW Medicine.

The team is now working on a possible blood test to determine if people are at elevated risk of suicide.

"We now know the mechanism and the molecule involved, so we have to find a simple way of testing it," says Associate Professor Guillemin.

Ultimately, it is hoped that medical practitioners will be able to stop the production of quinolinic acid by using specific enzyme inhibitors blocking its production. Recently published clinical studies have shown the anaesthetic ketamine, which inhibits glutamate signalling, may be effective in combating depression, although its side effects currently limit its use.

Related Stories

Countering brain chemical could prevent suicides

date Dec 14, 2012

(Medical Xpress)—Researchers have found the first proof that a chemical in the brain called glutamate is linked to suicidal behavior, offering new hope for efforts to prevent people from taking their own ...

Scientists develop new strategy that may improve cognition

date Jun 30, 2010

For the first time, scientists have linked a brain compound called kynurenic acid to cognition, possibly opening doors for new ways to enhance memory function and treat catastrophic brain diseases, according to a new study ...

Recommended for you

Targeting depression with deep brain stimulation

date 37 minutes ago

The darkest day of Marjorie Stowe's depression came when her long-time psychiatrist told her she obviously was choosing to resist the healing effects of one medication after another, psychotherapy, electric ...

The advantages of multilingualism

date 23 hours ago

'Multilingualism is not a problem, it's a gift.' So says Leena Huss, linguist and research leader of the minority studies programme at the Hugo Valentin Centre at Uppsala University.

Personal growth follows trauma for most soldiers

date Apr 27, 2015

More than half of soldiers who experience trauma also report strong psychological benefits, such as stronger intimate relationships, spiritual growth, and a greater appreciation of life because of their difficult ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.